These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1127 related items for PubMed ID: 29253680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D.
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
    Rahman Z, Wong CH, Dexter M, Olsson G, Wong M, Gebsky V, Nahar N, Wood A, Byth K, King M, Bleasel AB.
    Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
    Muñoz-Lopetegi A, López-González FJ, Rodríguez-Osorio X, Pato Pato A, Bellas Lamas P, Abella-Corral J, Castro Vilanova MD, Garea MJ, Gil López JA, Ruiz-Martínez J, Poza JJ.
    Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A, Ilvento L, Rizzi R, Doccini V, Leo MC, Pugi A, De Masi S, Guerrini R.
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [Abstract] [Full Text] [Related]

  • 13. The effects of lacosamide on depression and anxiety in patients with epilepsy.
    Moseley BD, Cole D, Iwuora O, Strawn JR, Privitera M.
    Epilepsy Res; 2015 Feb; 110():115-8. PubMed ID: 25616463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: A prospective study.
    Zheng Y, Ding X, Guo Y, Chen Q, Wang W, Zheng Y, Wang S, Ding Y, Ding M.
    Epilepsy Behav; 2019 Nov; 100(Pt A):106400. PubMed ID: 31634729
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C, Placidi F, Liguori C, Mari L, Ulivi M, Ornello R, Pisani A, Mercuri NB, Izzi F.
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.